Starpharma Holdings Limited (ASX:SPL)
0.405
+0.010 (2.53%)
At close: Mar 6, 2026
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 170.07 million as of March 6, 2026. Its market cap has increased by 269.77% in one year.
Market Cap
170.07M
Enterprise Value
152.61M
Revenue
14.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 170.07M, an increase of 240.13%. That is a compound annual growth rate of 4.93%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 146.60M |
| Recce Pharmaceuticals | 138.81M |
| Tetratherix | 201.54M |
| Botanix Pharmaceuticals | 128.65M |
| Island Pharmaceuticals | 122.33M |
| Orthocell | 242.82M |
| Paradigm Biopharmaceuticals | 112.01M |
| Dimerix | 246.16M |